Systematic literature review on the safety and immunogenicity of rotavirus vaccines when co-administered with meningococcal vaccines

References

• Tate JE, Burton AH, Boschi-Pinto C, Parashar UD. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000–2013. Clin Infect Dis. 2016;62(Suppl 2):S96–S105. doi:10.1093/cid/civ1013.
   PubMed Web of Science ®Google Scholar
• ECDC. Expert opinion on rotavirus vaccination in infancy; 2017 [accessed 2019 Sept 24]. https://ecdc.europa.eu/en/publications-data/expert-opinion-rotavirus-vaccination-infancy#no-link
   Google Scholar
• Rotavirus vaccines. WHO position paper; 2013 January [accessed 2019 Sept 24]. https://www.who.int/wer/2013/wer8805.pdf
   Google Scholar
• WHO. Statement on risks and benefits of rotavirus vaccines Rotarix and RotaTeq; 2019 [accessed 2019 Sept 10]. https://www.who.int/vaccine_safety/committee/topics/rotavirus/rotarix_and_rotateq/statement_May_2015/en/
   Google Scholar
• European public assessment report (EPAR) summary for Rotarix; [accessed 2019 Sept 10]. https://www.ema.europa.eu/en/medicines/human/EPAR/rotarix.
   Google Scholar
• Prescribing information for Rotarix; [accessed 2019 Sept 10]. https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Rotarix/pdf/ROTARIX-PI-PIL.PDF
   Google Scholar
• European public assessment report (EPAR) summary for Rotateq; [accessed 2019 Sept 10]. https://www.ema.europa.eu/en/medicines/human/EPAR/rotateq.
   Google Scholar
• Prescribing information for Rotateq; [accessed 2019 Sept 10]. https://www.merck.com/product/usa/pi_circulars/r/rotateq/rotateq_pi.pdf
   Google Scholar
• WHO prequalified vaccines: Rotavac; [accessed 2019 Sept 10]. https://extranet.who.int/gavi/PQ_Web/PreviewVaccine.aspx?nav=0&ID=314
   Google Scholar
• WHO prequalified vaccines: Rotasiil; [accessed 2019 Sept 10]. https://extranet.who.int/gavi/PQ_Web/PreviewVaccine.aspx?nav=0&ID=355&AspxAutoDetectCookieSupport=1
   Google Scholar
• WHO prequalified vaccines listing; 2019 Sept 18. [accessed 2019 Sept 24]. https://extranet.who.int/gavi/PQ_Web/.
   Google Scholar
• Borrow R, Alarcon P, Carlos J, Caugant DA, Christensen H, Debbag R, De Wals P, Echaniz-Aviles G, Findlow J, Head C, et al. The global meningococcal initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection. Expert Rev Vaccines. 2017;16:313–28. doi:10.1080/14760584.2017.1258308.
   PubMed Web of Science ®Google Scholar
• Pelton SI. The global evolution of meningococcal epidemiology following the introduction of meningococcal vaccines. J Adolesc Health. 2016;59:S3–S11. doi:10.1016/j.jadohealth.2016.04.012.
   PubMed Web of Science ®Google Scholar
• Burman C, Serra L, Nuttens C, Presa J, Balmer P, York L. Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination. Hum Vaccin Immunother. 2019;15:459–69. doi:10.1080/21645515.2018.1528831.
   PubMed Web of Science ®Google Scholar
• WHO vaccine-preventable diseases: monitoring system. global summary; 2019. http://apps.who.int/immunization_monitoring/globalsummary/schedules
   Google Scholar
• Public Health England, UK immunisation schedule: the green book, chapter 11; September 2019 [accessed 2019 Nov 05]. https://www.gov.uk/government/publications/immunisation-schedule-the-green-book-chapter-11.
   Google Scholar
• Moreno-Pérez D, Álvarez García FJ, Álvarez Aldeán J, Cilleruelo Ortega MJ, Garcés Sánchez M, García Sánchez N, Hernández Merino Á, Méndez Hernández M, M MM, Montesdeoca Melián A, et al. Immunisation schedule of the Spanish association of paediatrics: 2019 recommendations. Anales De Pediatría (English Edition). 2019;90:56.e51–56.e59. doi:10.1016/j.anpede.2018.11.001.
   Google Scholar
• Smith LE, Amlôt R, Weinman J, Yiend J, Rubin GJ. A systematic review of factors affecting vaccine uptake in young children. Vaccine. 2017;35:6059–69. doi:10.1016/j.vaccine.2017.09.046.
   PubMed Web of Science ®Google Scholar
• Scottish intercollegiate guidelines network, critical appraisal notes and checklists; [accessed 2019 Sept 10]. https://www.sign.ac.uk/checklists-and-notes.html
   Google Scholar
• Martinon-Torres F, Boisnard F, Thomas S, Sadorge C, Borrow R. Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib). Vaccine. 2017;35:3764–72. doi:10.1016/j.vaccine.2017.05.043.
   PubMed Web of Science ®Google Scholar
• Haidara FC, Tapia MD, Sow SO, Doumbia M, Coulibaly F, Diallo F, Traore A, Kodio M, Kelly CL, Fitzpatrick M, et al. Evaluation of a booster dose of pentavalent rotavirus vaccine coadministered with measles, yellow fever, and meningitis a vaccines in 9-month-old malian infants. J Infect Dis. 2018;218:606–13. doi:10.1093/infdis/jiy215.
   PubMed Web of Science ®Google Scholar
• Klein NP, Abu-Elyazeed R, Baine Y, Cheuvart B, Silerova M, Mesaros N. Immunogenicity and safety of the Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine co-administered with human rotavirus, hepatitis A and 13-valent pneumococcal conjugate vaccines: results from a phase III, randomized, multicenter study in infants. Hum Vaccin Immunother. 2019;15:327–38. doi:10.1080/21645515.2018.1526586.
   PubMed Web of Science ®Google Scholar
• O’Ryan M, Stoddard J, Toneatto D, Wassil J, Dull PM. A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program. Drugs. 2014;74:15–30. doi:10.1007/s40265-013-0155-7.
   PubMed Web of Science ®Google Scholar
• Martinon-Torres F, Diez-Domingo J, Feroldi E, Jordanov E, B’Chir S, Da Costa X. Evaluation of a hexavalent-pentavalent-hexavalent infant primary vaccination series followed by a pentavalent booster vaccine in healthy infants and toddlers. Pediatr Infect Dis J. 2019;38:317–22. doi:10.1097/inf.0000000000002231.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Borrow R, Da Costa X, Richard P, Eymin C, Boisnard F, Lockhart S. Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants. Vaccine. 2017;35:452–58. doi:10.1016/j.vaccine.2016.11.053.
   PubMed Web of Science ®Google Scholar
• Tregnaghi M, Lopez P, Stamboulian D, Grana G, Odrljin T, Bedell L, Dull PM. Immunogenicity and safety of a quadrivalent meningococcal polysaccharide CRM conjugate vaccine in infants and toddlers. Int J Infect Dis. 2014;26:22–30. doi:10.1016/j.ijid.2014.03.1390.
   PubMed Web of Science ®Google Scholar
• Block SL, Shepard J, Garfield H, Xie F, Han L, Dull PM, Smolenov I. Immunogenicity and safety of a 3- and 4-dose vaccination series of a meningococcal ACWY conjugate vaccine in infants: results of a phase 3b, randomized, open-label trial. Pediatr Infect Dis J. 2016;35:e48–59. doi:10.1097/inf.0000000000000965.
   PubMed Web of Science ®Google Scholar
• Klein NP, Reisinger KS, Johnston W, Odrljin T, Gill CJ, Bedell L, Dull P. Safety and immunogenicity of a novel quadrivalent meningococcal CRM-conjugate vaccine given concomitantly with routine vaccinations in infants. Pediatr Infect Dis J. 2012;31:64–71. doi:10.1097/INF.0b013e31823dce5c.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Borrow R, Kitchin N, Baudin M, Thomas S, Fiquet A. Results from a randomized clinical trial of coadministration of RotaTeq, a pentavalent rotavirus vaccine, and NeisVac-C, a meningococcal serogroup C conjugate vaccine. Clin Vaccine Immunol. 2011;18:878–84. doi:10.1128/cvi.00437-10.
   PubMedGoogle Scholar
• Bryan P, Seabroke S, Wong J, Donegan K, Webb E, Goldsmith C, Vipond C, Feavers I. Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study. Lancet Child Adolesc Health. 2018;2:395–403. doi:10.1016/s2352-4642(18)30103-2.
   PubMedGoogle Scholar
• Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Thollot F, Garcia-Corbeira P, Damaso S, Han HH, Bouckenooghe A. Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe. Vaccine. 2010;28:5272–79. doi:10.1016/j.vaccine.2010.05.057.
   PubMed Web of Science ®Google Scholar
• Sadarangani M, Barlow S, Anthony M, Pollard AJ. Four component meningococcal capsular group B vaccine in preterm infants. Pediatr Infect Dis J. 2017;6:309–10. doi:10.1093/jpids/pix013.
   Google Scholar
• GBD Meningitis Collaborators.Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global burden of disease study 2016. Lancet Neurol. 2016;2018(17):1061–82. doi:10.1016/s1474-4422(18)30387-9.
   Google Scholar
• Dagan R, Poolman J, Siegrist CA. Glycoconjugate vaccines and immune interference: A review. Vaccine. 2010;28:5513–23. doi:10.1016/j.vaccine.2010.06.026.
   PubMed Web of Science ®Google Scholar
• CDC, Principles of vaccination - immunology and vaccine-preventable diseases; [accessed 2019 Sept 10]. https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/prinvac.pdf
   Google Scholar
• Zhang L, Wang W, Wang S. Effect of vaccine administration modality on immunogenicity and efficacy. Expert Rev Vaccines. 2015;14:1509–23. doi:10.1586/14760584.2015.1081067.
   PubMed Web of Science ®Google Scholar
• Emperador DM, Velasquez DE, Estivariz CF, Lopman B, Jiang B, Parashar U, Anand A, Zaman K. Interference of monovalent, bivalent, and trivalent oral poliovirus vaccines on monovalent rotavirus vaccine immunogenicity in rural Bangladesh. Clin Infect Dis. 2015;62:150–56. doi:10.1093/cid/civ807.
   PubMed Web of Science ®Google Scholar
• Tregnaghi MW, Abate HJ, Valencia A, Lopez P, Da STR, Rivera L, Rivera Medina DM, Saez-Llorens X, Gonzalez ASE, De LT, et al. Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America. Pediatr Infect Dis J. 2011;30:e103–108. doi:10.1097/INF.0b013e3182138278.
   PubMed Web of Science ®Google Scholar